115 related articles for article (PubMed ID: 22072433)
1. A weekly administered sustained-release growth hormone reduces visceral fat and waist circumference in abdominal obesity.
Hong JW; Park JK; Lim CY; Kim SW; Chung YS; Kim SW; Lee EJ
Horm Metab Res; 2011 Dec; 43(13):956-61. PubMed ID: 22072433
[TBL] [Abstract][Full Text] [Related]
2. L-arginine for the treatment of centrally obese subjects: a pilot study.
Hurt RT; Ebbert JO; Schroeder DR; Croghan IT; Bauer BA; McClave SA; Miles JM; McClain CJ
J Diet Suppl; 2014 Mar; 11(1):40-52. PubMed ID: 24409974
[TBL] [Abstract][Full Text] [Related]
3. Comparative relation of general, central, and visceral adiposity measures for coronary artery calcium in subjects without previous coronary events.
Ho JS; Cannaday JJ; Barlow CE; Willis B; Haskell WL; FitzGerald SJ
Am J Cardiol; 2009 Oct; 104(7):943-6. PubMed ID: 19766761
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
5. Development of a sustained-release recombinant human growth hormone formulation.
Kwak HH; Shim WS; Choi MK; Son MK; Kim YJ; Yang HC; Kim TH; Lee GI; Kim BM; Kang SH; Shim CK
J Control Release; 2009 Jul; 137(2):160-5. PubMed ID: 19332090
[TBL] [Abstract][Full Text] [Related]
6. [Changes of waist circumference distribution and the prevalence of abdominal adiposity among Chinese adults from 1993 to 2006].
Wang HJ; Wang ZH; Yu WT; Zhang B; Zhai FY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):953-8. PubMed ID: 19173871
[TBL] [Abstract][Full Text] [Related]
7. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
Donohoe CL; Doyle SL; McGarrigle S; Cathcart MC; Daly E; O'Grady A; Lysaght J; Pidgeon GP; Reynolds JV
Br J Surg; 2012 Mar; 99(3):387-96. PubMed ID: 22241325
[TBL] [Abstract][Full Text] [Related]
8. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.
Kadooka Y; Sato M; Imaizumi K; Ogawa A; Ikuyama K; Akai Y; Okano M; Kagoshima M; Tsuchida T
Eur J Clin Nutr; 2010 Jun; 64(6):636-43. PubMed ID: 20216555
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.
Pereira AM; van der Klaauw AA; Koppeschaar HP; Smit JW; van Thiel SW; van Doorn J; Biermasz NR; Roelfsema F; Romijn JA
Br J Clin Pharmacol; 2006 Apr; 61(4):451-5. PubMed ID: 16542206
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone reduces central obesity in polycystic ovary syndrome women.
Asadipooya K; Kalantar-Hormozi M; Nabipour I
Gynecol Endocrinol; 2012 Jan; 28(1):16-9. PubMed ID: 21756079
[TBL] [Abstract][Full Text] [Related]
11. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone.
Bell W; Davies JS; Evans WD; Scanlon MF; Mullen R
Am J Hum Biol; 2004; 16(5):533-43. PubMed ID: 15368601
[TBL] [Abstract][Full Text] [Related]
12. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women.
Franco C; Koranyi J; Brandberg J; Lönn L; Bengtsson BK; Svensson J; Johannsson G
Growth Horm IGF Res; 2009 Apr; 19(2):112-20. PubMed ID: 18752977
[TBL] [Abstract][Full Text] [Related]
13. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
[TBL] [Abstract][Full Text] [Related]
14. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
15. Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency.
Ferrante E; Malavazos AE; Giavoli C; Ermetici F; Coman C; Bergamaschi S; Profka E; Briganti S; Ronchi CL; Passeri E; Corbetta S; Lania AG; Spada A; Iacobellis G; Ambrosi B; Beck-Peccoz P
Nutr Metab Cardiovasc Dis; 2013 May; 23(5):459-65. PubMed ID: 22118958
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.
Kim SJ; Hahn SK; Kim MJ; Kim DH; Lee YP
J Control Release; 2005 May; 104(2):323-35. PubMed ID: 15907583
[TBL] [Abstract][Full Text] [Related]
17. Total and abdominal obesity among rural Chinese women and the association with hypertension.
Zhang X; Yao S; Sun G; Yu S; Sun Z; Zheng L; Xu C; Li J; Sun Y
Nutrition; 2012 Jan; 28(1):46-52. PubMed ID: 21621392
[TBL] [Abstract][Full Text] [Related]
18. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
19. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
[TBL] [Abstract][Full Text] [Related]
20. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
